Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Public ClinicalTrials.gov record NCT01275248. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Who Have Not Adequately Responded To Treatment With A Serotonin Reuptake Inhibitor
Study identification
- NCT ID
- NCT01275248
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Transcept Pharmaceuticals
- Industry
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- Ondansetron Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2010
- Primary completion
- Aug 31, 2015
- Completion
- Aug 31, 2015
- Last update posted
- Jan 17, 2013
2011 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwestern Research, Inc. | Beverly Hills | California | 90210 | — |
| Sun Valley Research Center | Imperial | California | 92251 | — |
| Pacific Institute for Medical Research | Los Angeles | California | 90024 | — |
| Compass Research, LLC | Orlando | Florida | 32806 | — |
| University of South Florida | St. Petersburg | Florida | 33701 | — |
| Emory University | Atlanta | Georgia | 30306 | — |
| Carman Research | Smyrna | Georgia | 30080 | — |
| McLean Hospital | Belmont | Massachusetts | 02478 | — |
| Beacon Clinical Research, LLC | New Bedford | Massachusetts | 02740 | — |
| Ambulatory Research Center, Dept of Psychiatry | Minneapolis | Minnesota | 55454 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Biobehavioral Institute, Hofstra | Great Neck | New York | 11021 | — |
| Eastside Comprehensive Medical Center, LLC | New York | New York | 10021 | — |
| Columbia University Medical Center NYS Psychiatric Institute | New York | New York | 10032 | — |
| Montefiore Medical Center, Child Psychiatry Annex | The Bronx | New York | 10467 | — |
| Richard H. Weisler, MD, PA, and Associates | Raleigh | North Carolina | 27609 | — |
| Quest Therapeutics of Avon Lake | Avon Lake | Ohio | 44012 | — |
| Lindner Center of HOPE University of Cincinnati | Mason | Ohio | 45040 | — |
| The Body Dysmorphic Disorder (BDD) Program | Providence | Rhode Island | 02903 | — |
| Clinical Trials of Texas, Inc | San Antonio | Texas | 78229 | — |
| Dean Foundation | Middleton | Wisconsin | 53562 | — |
| The Rogers Center for Research and Training | Milwaukee | Wisconsin | 53227 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01275248, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2013 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01275248 live on ClinicalTrials.gov.